This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Women's Health  • Women's Health, Other  • Dermatologic Disorders, Other  • Alert me on articles by topic

Susan M. Cooper, MRCP; Fenella Wojnarowska, DM, FRCP

Arch Dermatol. 2006;142:289-294.

Objective  To record the clinical features, symptomatic response to treatment, and resolution of clinical signs in a large cohort of women with erosive lichen planus of the vulva.

Design  Descriptive, prospective cohort study with a mean follow-up of 72 months.

Setting  The vulval clinics of a teaching and district general hospital in Oxfordshire, England.

Patients  One hundred fourteen adult women with a definite clinical diagnosis of erosive lichen planus of the vulva.

Interventions  Patients received topical corticosteroids with or without other topical preparations and systemic treatments as part of their normal care.

Main Outcome Measures  Symptomatic response to individual treatments (good, partial, or poor), overall symptomatic response to treatment and with time (good, partial, no change, or worse), response of the vulval signs (total, partial, moderate, minor, same, or worse), and the presence or absence of moderate or severe scarring.

Results  The mean age at onset of vulval symptoms was 56.9 years. First-line therapy was an ultrapotent topical corticosteroid in 89 women (78%), of whom 63 (71%) were symptom free while receiving treatment. Overall and with time, 86 women (75%) improved with treatment, including 62 (54%) who were symptom free (good response) and 24 (21%) who had a partial response. Eighteen (16%) had no change and 10 (9%) were worse. Overall response of the vulval signs was recorded in 113 patients. Only 10 (9%) of these had complete resolution of clinical signs excepting scarring, with 57 (50%) showing resolution of erosions. Squamous cell carcinoma developed in 3 women (3%).

Conclusions  Topical ultrapotent corticosteroid is an effective treatment for erosive lichen planus of the vulva, giving relief of symptoms in 71%. With time and treatment, three quarters of patients can expect overall improvement of symptoms and one half, healing of erosions.

Author Affiliations: Department of Dermatology, Churchill Hospital, Oxford, England.

RELATED ARTICLE

Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers
June K. Robinson and Marcia Ramos-e-Siliva
Arch Dermatol. 2006;142(3):362-364.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Erosive Vulvar Lichen Planus Improves with Treatment
JWatch Women's Health 2006;2006:5-5.
FULL TEXT  

Ultrapotent Topical Corticosteroids Are Effective for Erosive Lichen Planus of the Vulva
Journal Watch Dermatology 2006;2006:9-9.
FULL TEXT  

Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers.
Robinson and Ramos-e-Siliva
Arch Dermatol 2006;142:362-364.
FULL TEXT